We demonstrate, for the first time, that CHAF1A is sufficient to block neuronal differentiation in three different models (zebrafish NC, human NC, and human NB), promotes NB oncogenesis, and contributes to the resistance of NB to RA, a standard maintenance therapy. The gene discussed is CHAF1A; the disease is neuroblastoma.